• / Free eNewsletters & Magazine
  • / My Account
Home>Cigna will no longer cover opioid OxyContin as preferred option next year

Cigna will no longer cover opioid OxyContin as preferred option next year

Cigna will no longer cover opioid OxyContin as preferred option next year

10/06/2017

Cigna Corp. (CI) said that, as part of an opioid-reduction plan, the company will no longer cover opioid OxyContin as a preferred option for group commercial drug lists starting next year. OxyContin is manufactured by the privately-held drugmaker Purdue Pharma, which has been widely criticized -- and sued -- for playing a major role in the opioid epidemic. Cigna said that individuals using OxyContin for hospice care or cancer pain will continue to have the pain medication covered next year. The health insurer said it is in the process of informing customers with OxyContin prescriptions and their doctors about the change; Cigna will consider approving coverage if the doctor believes the treatment is "medically necessary." Cigna said the Wednesday news is part of a goal to reduce opioid use among customers by 25% by 2019. Cigna shares declined 0.7% in Wednesday trade. Shares slumped 13% in Thursday trade, and have surged 13% over the last three months, compared with a 4.9% rise in the S&P 500 .

-Emma Court; 415-439-6400; AskNewswires@dowjones.com

 

(END) Dow Jones Newswires

10-05-17 1552ET

Copyright (c) 2017 Dow Jones & Company, Inc.

1

©2017 Morningstar Advisor. All right reserved.